Maternal circulating PlGF concentrations and placenta-related pregnancy complications: First results from the CoLab...

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Biomarker Discovery

Background:

• Circulating angiogenic factors are potential preeclampsia biomarkers, but study heterogeneity limits their diagnostic utility.
• The Global CoLaboratory aims to merge individual sample data for meta-analysis of angiogenic factors.
• Standardizing measurements across different analytical platforms is crucial for reliable biomarker analysis.

Purpose of the Study:

• To combine pregnancy angiogenic factor studies for meta-analysis.
• To investigate the diagnostic and predictive properties of angiogenic markers in preeclampsia and related pregnancy complications.
• To assess the standardization of measurements from disparate analytical platforms, focusing initially on placental growth factor (PlGF).

Main Methods:

• Data from 15 cohorts (1442 cases, 11,512 non-cases) were aggregated.
• Individual PlGF measurements from four analytical platforms were used.
• Data underwent transformations and standardization for specific platforms and globally, stratified by gestational age.

Main Results:

• An algorithm was developed to merge PlGF measurements from different platforms.
• Non-case distributions were utilized to standardize case results.
• The feasibility of using standardized PlGF measurements for preeclampsia diagnosis was confirmed.

Conclusions:

• The developed approach demonstrates the feasibility of standardizing angiogenic factor measurements.
• This methodology can be extended to other angiogenic factors for prediction and diagnosis.
• Future research can apply this to other placenta-related disorders.